NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00986154,Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).,https://clinicaltrials.gov/study/NCT00986154,,COMPLETED,Evaluation of heparin/edoxaban tosylate (DU176b) versus heparin/warfarin in preventing recurrence of blood clots in patients with acute symptomatic deep-vein blood clots in the legs and/or blood clots in the lungs.,YES,Venous Thromboembolism|Deep Vein Thrombosis (DVT)|Pulmonary Embolism (PE)|Thromboembolism|Venous Thrombosis,DRUG: edoxaban tosylate(DU-176b)|DRUG: low molecular weight heparin/unfractionated heparin|DRUG: warfarin,"Symptomatic Recurrent VTE, i.e., the Composite of DVT, Non-fatal PE, and Fatal PE, Symptomatic recurrent Venous Thromboembolism (VTE), i.e., the composite of deep Vein Thrombosis (DVT), non-fatal Pulmonary Embolism (PE), and fatal PE occurring during the Overall Study Period.

Overall Study Period defined as ""The time from the reference date (randomization date/initial dose of study drug date) to the last study follow-up visit."", 12 months from time of randomization","The Composite Clinical Outcome of Symptomatic Recurrent VTE and All-cause Mortality, 12 months from time of randomization|Clinically Relevant Bleeding (i.e., Major or Clinically Relevant Non-major Bleeding) Occurring During Treatment, Clinically relevant bleeding (i.e., major or clinically relevant non-major bleeding) occurring during treatment plus 3 days after their last dose for that time period., 12 months from time of randomization",,Daiichi Sankyo,,ALL,"ADULT, OLDER_ADULT",PHASE3,8292,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",DU176b-D-U305|The Edoxaban Hokusai VTE Study,2009-10,2013-04,2013-04,2009-09-29,2015-02-25,2019-03-05,"Investigational Site 7103, Mobile, Alabama, 36608, United States|Investigational Site 7132, Montgomery, Alabama, 36116, United States|Investigational Site 7126, Phoenix, Arizona, 85006, United States|Investigational Site 7139, Little Rock, Arkansas, 72205, United States|Investigational Site 1070, Anaheim, California, 92801, United States|Investigational Site 7125, Los Alamitos, California, 90720, United States|Investigational Site 1093, Monterey, California, 93940, United States|Investigational Site 1069, Palm Springs, California, 92262, United States|Investigational Site 7150, San Diego, California, 92123, United States|Investigational Site 1089, Vista, California, 92083, United States|Investigational Site 1012, Aurora, Colorado, 80012, United States|Investigational Site 1013, Boulder, Colorado, 80303, United States|Investigational Site 1017, Denver, Colorado, 80218, United States|Investigational Site 1018, Lakewood, Colorado, 80228, United States|Investigational Site 1019, Littleton, Colorado, 80120-4413, United States|Investigational Site 1022, Thornton, Colorado, 80260, United States|Investigational Site 1023, Thornton, Colorado, 80260, United States|Brandon, Florida, United States|Investigational Site 1071, Clearwater, Florida, 33756, United States|Investigational Site 7117, Fort Myers, Florida, 33907, United States|Investigational Site 7106, Gainesville, Florida, 32605, United States|Investigational Site 1005, Ocoee, Florida, 34761, United States|Investigational Site 1006, Orlando, Florida, 32806, United States|Investigational Site 7127, Saint Petersburg, Florida, 33707, United States|Investigational Site 7144, Sarasota, Florida, 34232, United States|Investigational Site 1007, Winter Park, Florida, 32789, United States|Investigational Site 7104, Albany, Georgia, 31701, United States|Investigational Site 1095, Columbus, Georgia, 31904, United States|Investigational Site 1080, Jonesboro, Georgia, 30236, United States|Investigational Site 7146, Savannah, Georgia, 31419, United States|Investigational Site 1098, Park Ridge, Illinois, 60068, United States|Carmel, Indiana, United States|Investigational Site 7115, Paducah, Kentucky, 42003, United States|Investigational Site 1065, Covington, Louisiana, 70433, United States|Investigational Site 1068, Baltimore, Maryland, 21215, United States|Investigational Site 1037, Westminster, Maryland, 21157, United States|Investigational Site 1038, Westminster, Maryland, 21157, United States|Investigational Site 7133, Kansas City, Missouri, 64128, United States|Investigational Site 7147, Butte, Montana, 59701, United States|Investigational Site 1039, Las Vegas, Nevada, 89169, United States|Investigational Site 7143, Rochester, New York, 14642, United States|Investigational Site 7135, Durham, North Carolina, 27710, United States|Investigational Site 7145, Statesville, North Carolina, 28625, United States|Investigational Site 7138, Maumee, Ohio, 43537, United States|Investigational Site 7122, Toledo, Ohio, 43606, United States|Investigational Site 7152, Bend, Oregon, 97701, United States|Portland, Oregon, United States|Investigational Site 1004, Camp Hill, Pennsylvania, 17011, United States|Investigational Site 7109, Ephrata, Pennsylvania, 17522, United States|Investigational Site 1049, Kingston, Pennsylvania, 18704, United States|Investigational Site 7109, Lancaster, Pennsylvania, 17602, United States|Investigational Site 7154, Sellersville, Pennsylvania, United States|Investigational Site 7128, Uniontown, Pennsylvania, United States|Investigational Site 1031, Easley, South Carolina, 29640, United States|Investigational Site 1032, Greenville, South Carolina, 29605, United States|Investigational Site 1034, Greenville, South Carolina, 29605, United States|Investigational Site 1033, Greenville, South Carolina, 29615, United States|Investigational Site 1035, Seneca, South Carolina, 29672, United States|Investigational Site 1036, Spartanburg, South Carolina, 29307, United States|Investigational Site 1009, Arlington, Texas, 76014-2084, United States|Investigational Site 1050, Dallas, Texas, United States|Investigational Site 1047, Fort Worth, Texas, 76104, United States|Investigational Site 7105, Fort Worth, Texas, 76109, United States|Investigational Site 1048, Fort Worth, Texas, 76132, United States|Investigational Site 1059, Midland, Texas, United States|Investigational Site 1040, New Braunfels, Texas, 78130, United States|Investigational Site 1041, Odessa, Texas, United States|Investigational Site 1002, San Antonio, Texas, 78229, United States|Investigational Site 1058, Sugar Land, Texas, United States|Investigational Site 1042, Tyler, Texas, United States|Investigational Site 1008, Waco, Texas, United States|Investigational Site 7123, Salt Lake City, Utah, United States|Investigational Site 1003, Fredericksburg, Virginia, United States|Investigational Site 1025, Newport News, Virginia, United States|Investigational Site 1024, Norfolk, Virginia, United States|Investigational Site 1066, Randallstown, Virginia, United States|Investigational Site 1030, Virginia Beach, Virginia, United States|Investigational Site 7120, Seattle, Washington, United States|Investigational Site 1076, Tacoma, Washington, United States|Investigational Site 1053, Vancouver, Washington, United States|Investigational Site 1056, Vancouver, Washington, United States|Investigational Site 1057, Vancouver, Washington, United States|Investigational Site 1100, Buenos Aires, Argentina|Investigational Site 1103, Buenos Aires, Argentina|Investigational Site 1106, Buenos Aires, Argentina|Investigational Site 1108, Buenos Aires, Argentina|Investigational Site 1104, Cordoba, Argentina|Investigational Site 1110, Pcia De Corrientes, Argentina|Investigational Site 1109, Santa Fe, Argentina|Investigational Site 4205, Bedford Park, Australia|Investigational Site 4209, Box Hill, Australia|Investigational Site 4210, Clayton, Australia|Investigational Site 4211, Fremantle, Australia|Investigational Site 4213, Garran, Australia|Kogarah, Australia|Investigational Site 4207, Perth, Australia|Investigational Site 4203, Redcliffe, Australia|Investigational Site 4206, Saint Leonards NSW, Australia|Investigational Site 4214, South Brisbane, Australia|Investigational Site 4212, Westmead NSW, Australia|Investigational Site 4200, Windsor, Australia|Investigational Site 2802, Feldkirch, Austria|Investigational Site 2803, Graz, Austria|Investigational Site 2800, Innsbruck, Austria|Investigational Site 2804, Linz, Austria|Sr. M. Restitutagasse, Austria|Vienna, Austria|Investigational Site 2703, Gomel, Belarus|Investigational Site 2704, Grodno, Belarus|Investigational Site 2700, Minsk, Belarus|Investigational site 2701, Minsk, Belarus|Investigational Site 2702, Minsk, Belarus|Investigational Site 2705, Mogilev, Belarus|Investigational Site 1608, Aalst, Belgium|Investigational Site 1602, Lier, Belgium|Investigational Site 2905, Belo Horizonte, Brazil|Investigational Site 2914, Campinas, Brazil|Investigational Site 2901, Curitiba, Brazil|Investigational Site 2903, Curitiba, Brazil|Investigational Site 2912, Porto Alegre, Brazil|Investigational Site 2915, Porto Alegre, Brazil|Investigational Site 2917, Porto Alegre, Brazil|Investigational Site 2904, Sao Bernardo do Campo, Brazil|Investigational Site 2900, Sao Paulo, Brazil|Investigational Site 2902, Sao Paulo, Brazil|Investigational Site 2906, Sao Paulo, Brazil|Investigational Site 2910, Sao Paulo, Brazil|Investigational Site 2911, Sao Paulo, Brazil|Investigational Site 2006, Edmonton, Alberta, Canada|Investigational Site 2001, London, Ontario, Canada|Investigational Site 2007, Newmarket, Ontario, Canada|Investigational Site 2000, Ottawa, Ontario, Canada|Investigational Site 2003, Richmond Hill, Ontario, Canada|Investigational Site 2005, Halifax, Canada|Investigational Site 2004, Montreal, Canada|Investigational Site 1200, Santiago, Chile|Investigational Site 1204, Santiago, Chile|Investigational Site 4301, Beijing, China|Investigational Site 4302, Beijing, China|Investigational Site 4306, Beijing, China|Investigational Site 4321, Beijing, China|Investigational Site 4327, Beijing, China|Investigational Site 4337, Beijing, China|Investigational Site 4316, Guangzhou, China|Investigational Site 4310, Hangzhou, China|Hebei Province, China|Investigational Site 4325, Jiangsu, China|Investigational Site 4317, Kunming, China|Investigational Site 4328, Nanjing, China|Investigational Site 4319, Nanning, China|Investigational Site 4313, Qingdao, China|Investigational Site 4303, Shanghai, China|Investigational Site 4324, Shanghai, China|Investigational Site 4330, Shanghai, China|Investigational Site 4335, Shanghai, China|Investigational Site 4326, Shenyang, China|Investigational Site 4308, Sichuan Province, China|Investigational Site 4318, Taiyuan, China|Investigational Site 4320, Tianjin, China|Investigational site 4338, Xi'an, China|Investigational Site 4315, Yinchuan, China|Chodov, Czechia|Jihlava, Czechia|Investigational Site 1902, Liberec, Czechia|Investigational Site 1908, Olomouc, Czechia|Investigational Site 1905, Ostrava, Czechia|Investigational Site 1901, Plzen, Czechia|Investigational Site 1910, Plzen, Czechia|Investigational Site 1904, Praha, Czechia|Usti Nad Labem, Czechia|Investigational Site 6010, Aarhus, Denmark|Arhus N., Denmark|Copenhagen, Denmark|Investigational Site 6003, Herlev, Denmark|Ringvej, Denmark|Investigational Site 6001, Svendborg, Denmark|Investigational Site 2100, Tallinn, Estonia|Investigational Site 2101, Tallinn, Estonia|Investigational Site 2102, Tartu, Estonia|Investigational Site 3314, Agen, France|Investigational Site 3302, Amiens, France|Investigational Site 3311, Angers, France|Investigational Site 3321, Annecy, France|Investigational Site 3300, Arras, France|Investigational Site 3301, Besancon Cedex, France|Investigational Site 3329, Bordeaux, France|Investigational Site 3310, Brest, France|Investigational Site 3333, Cannes, France|Investigational Site 3327, Colombes Cedex, France|Investigational Site 3323, Dijon, France|Investigational Site 3307, Grenoble, France|Investigational Site 3322, Grenoble, France|Investigational Site 3325, Hetztessy, France|Investigational Site 3328, Le Mans, France|Investigational Site 3339, Lille, France|Lormont, France|Investigational Site 3318, Lyon, France|Investigational Site 3303, Montpellier, France|Nantes, France|Investigational Site 3319, Nice, France|Investigational Site 3308, Paris, France|Investigational Site 3312, Paris, France|Investigational Site 3313, Paris, France|Investigational Site 3337, Paris, France|Investigational Site 3335, Pessac, France|Investigational Site 3341, Pessac, France|Investigational Site 3336, Pierre Benite, France|Roskilde, France|Saint Aubin Surscie, France|Investigational Site 3305, Saint-Etienne Cedex, France|Investigational Site 3316, Toulon, France|Investigational Site 1718, Berlin, Germany|Investigational Site 1720, Bielefeld, Germany|Investigational Site 1715, Bruchsal, Germany|Investigational Site 1700, Darmstadt, Germany|Investigational Site 1719, Dortmund, Germany|Investigational Site 1701, Dresden, Germany|Investigational Site 1707, Dresden, Germany|Investigational Site 1721, Hamburg, Germany|Magdeburg, Germany|Investigational Site 1712, Mainz, Germany|Investigational Site 1704, Munchen, Germany|Investigational Site 1714, Nordhausen, Germany|Investigational Site 1711, Paderborn, Germany|Investigational Site 1706, Tubingen, Germany|Investigational Site 1708, Witten, Germany|Investigational Site 5413, Baja, Hungary|Investigational Site 5401, Budapest, Hungary|Investigational Site 5404, Budapest, Hungary|Investigational Site 5409, Budapest, Hungary|Investigational Site 5414, Budapest, Hungary|Investigational Site 5400, Debrecen, Hungary|Investigational Site 5402, Kecskemet, Hungary|Investigational Site 5405, Kistarcsa, Hungary|Maglodi, Hungary|Investigational Site 5407, Miskolc, Hungary|Investigational Site 5410, Pecs, Hungary|Rakoczi, Hungary|Investigational Site 5403, Szentes, Hungary|Investigational Site 5408, Szombathely, Hungary|Investigational Site 5412, Zalaegerszeg, Hungary|Zrinyi, Hungary|Ahmedabad, India|Andhra Pradesh, India|Investigational Site 4402, Bangalore, India|Investigational Site 4405, Bangalore, India|Investigational Site 4442, Bangalore, India|Investigational Site 4459, Bangalore, India|Investigational Site 4460, Bangalore, India|Investigational Site 4472, Bangalore, India|Gujarat, India|Gurgaon, India|Haryana, India|Investigational Site 5514, Holon, India|Investigational Site 4407, Hyderabad, India|Investigational Site 4430, Hyderabad, India|Investigational Site 4444, Hyderabad, India|Investigational Site 4451, Hyderabad, India|Karnataka, India|Kerala, India|Investigational Site 4420, Lucknow, India|Madhya Pradesh, India|Maharashtra, India|Investigational Site 4409, Mumbai, India|Investigational Site 4424, Mumbai, India|Investigational Site 4419, New Delhi, India|Investigational Site 4428, New Delhi, India|Investigational Site 4441, New Delhi, India|Investigational Site 4425, Pune, India|Investigational Site 4438, Pune, India|Investigational Site 4443, Pune, India|Investigational Site 4462, Pune, India|Punjab, India|Rajasthan, India|Investigational Site 4470, Secunderbad, India|Tamil Nadu, India|Uttar Pradesh, India|Vadodara, India|Visakhapatnam, India|Afula, Israel|Ashkelon, Israel|Hadera, Israel|Investigational Site 5506, Haifa, Israel|Investigational Site 5508, Haifa, Israel|Investigational Site 5500, Holon, Israel|Investigational Site 5501, Jerusalem, Israel|Investigational Site 5505, Kfar Saba, Israel|Investigational Site 5513, Nahariya, Israel|Investigational Site 5510, Petah-Tikva, Israel|Investigational Site 5512, Poriya, Israel|Investigational Site 5503, Tel Aviv, Israel|Investigational Site 5509, Tel Hashomer, Israel|Investigational Site 3508, Bergamo, Italy|Investigational Site 3506, Chieti, Italy|Investigational Site 3500, Emilia, Italy|Investigational Site 3504, Milano, Italy|Padova, Italy|Investigational Site 3502, Palermo, Italy|Investigational Site 3507, Parma, Italy|Investigational Site 3501, Pavia, Italy|Investigational Site 3505, Rozzano, Italy|Investigational Site 3510, Udine, Italy|Investigational Site 3503, Varese, Italy|Investigational Site 3509, Venezia, Italy|Investigational Site 6137, Aichi, Japan|Investigational Site 6104, Aomori, Japan|Investigational Site 6117, Chiba, Japan|Investigational Site 6119, Fukuoka, Japan|Fukuoka, Japan|Investigational Site 6110, Fukushima, Japan|Investigational Site 6150, Hiroshima, Japan|Investigational Site 6138, Hokkaido, Japan|Investigational Site 6141, Hokkaido, Japan|Investigational Site 6133, Hyogo, Japan|Hyogo, Japan|Investigational Site 6114, Ishikawa, Japan|Investigational Site 6144, Kagoshima, Japan|Investigational Site 6112, Kanagawa, Japan|Investigational Site 6123, Kumamoto, Japan|Investigational Site 6147, Kumamoto, Japan|Investigational Site 6148, Kumamoto, Japan|Investigational Site 6129, Mie, Japan|Investigational Site 6146, Nagano, Japan|Investigational Site 6139, Nagasaki, Japan|Investigational Site 6107, Niigata, Japan|Investigational Site 6152, Okayama, Japan|Investigational Site 6135, Okinawa, Japan|Investigational Site 6132, Osaka, Japan|Investigational Site 6130, Sapporo, Japan|Investigational Site 6143, Shizuoka, Japan|Investigational Site 6102, Tokyo, Japan|Investigational Site 6105, Tokyo, Japan|Investigational Site 6113, Tokyo, Japan|Investigational Site 6142, Tokyo, Japan|Investigational Site 6145, Tokyo, Japan|Investigational Site 6149, Tottori, Japan|Investigational Site 4513, Busan, Korea, Republic of|Investigational Site 4509, Daegu, Korea, Republic of|Investigational Site 4501, Gyeonggi-do, Korea, Republic of|Investigational Site 4506, Seoul, Korea, Republic of|Investigational Site 4507, Seoul, Korea, Republic of|Investigational Site 4508, Seoul, Korea, Republic of|Investigational Site 4515, Seoul, Korea, Republic of|Investigational Site 1303, Zapopan, Jalisco, Mexico|Investigational Site 1302, Monterrey, Nuevo Leon, Mexico|Investigational Site 1311, Col. Lomas Altas C.P, Mexico|Investigational Site 1304, Guadalajara, Mexico|Investigational Site 1312, Guadalajara, Mexico|Investigational Site 1300, Hermosillo, Mexico|Investigational Site 1305, Monterrey, Nuevo Leon, Mexico|Investigational Site 1308, San Luis Potosi, Mexico|Investigational Site 1301, Yucatan, Mexico|Investigational Site 3608, Alkmaar, Netherlands|Investigational Site 3607, Almere, Netherlands|Investigational Site 3617, Amersfoort, Netherlands|Investigational Site 3611, Amsterdam, Netherlands|Investigational Site 3609, Assen, Netherlands|Investigational Site 3603, Groningen, Netherlands|Investigational Site 3612, Heerlen, Netherlands|Investigational Site 3613, Hoofddorp, Netherlands|Investigational Site 3602, Nijmegen, Netherlands|Investigational Site 3615, Rotterdam, Netherlands|Investigational Site 4702, Auckland, New Zealand|Investigational Site 4703, Auckland, New Zealand|Investigational Site 4700, Christchurch, New Zealand|Investigational Site 4704, Wellington, New Zealand|Investigational Site 3701, Fredrikstad, Norway|Investigational Site 3700, Oslo, Norway|Pasig City, Philippines|Investigational Site 4800, Quezon City, Philippines|Investigational site 4801, Quezon City, Philippines|Investigational Site 4802, Quezon City, Philippines|Investigational Site 5015, Bialystok, Poland|Investigational Site 5005, Krakow, Poland|Investigational Site 5019, Olsztyn, Poland|Investigational Site 5018, Tarnow, Poland|Investigational Site 5003, Warszawa, Poland|Investigational Site 5007, Warszawa, Poland|Investigational Site 5008, Warszawa, Poland|Investigational Site 5014, Warszawa, Poland|Barnaul, Russian Federation|Investigational Site 3023, Chelyabinsk, Russian Federation|Investigational Site 3017, Irkutsk, Russian Federation|Investigational Site 3019, Kemerovo, Russian Federation|Investigational Site 3020, Krasnoyarsk, Russian Federation|Investigational Site 3030, Krasnoyarsk, Russian Federation|Investigational Site 3029, Moscow, Russian Federation|Investigational Site 3028, Novosibirsk, Russian Federation|Investigational Site 3009, Omsk, Russian Federation|Investigational Site 3022, Ryazan, Russian Federation|Saratov, Russian Federation|Investigational Site 3024, Sochi, Russian Federation|Investigational Site 3000, St. Petersburg, Russian Federation|Investigational Site 3003, St. Petersburg, Russian Federation|Investigational Site 3027, St. Petersburg, Russian Federation|Investigational Site 3025, Tyumen, Russian Federation|Investigational Site 3016, Ufa, Russian Federation|Investigational Site 3004, Yaroslavl, Russian Federation|Investigational Site 3010, Yaroslavl, Russian Federation|Investigational Site 5900, Outram Road, Singapore|Investigational Site 5902, Singapore, Singapore|Investigational Site 4912, Cape Town, South Africa|Investigational Site 4907, Centurion, South Africa|Investigational Site 4901, Johannesburg, South Africa|Investigational Site 4905, Johannesburg, South Africa|Investigational Site 4909, Johannesburg, South Africa|Investigational Site 4910, Johannesburg, South Africa|Investigational Site 4908, Lyttleton, South Africa|Investigational Site 4903, Pretoria, South Africa|Investigational Site 4906, Pretoria, South Africa|Investigational Site 4904, Somerset West, South Africa|Investigational Site 4900, Worcester, South Africa|Investigational site 1503, Barcelona, Spain|Investigational Site 1502, Cabra, Spain|Investigational Site 3900, Hallingsjo, Sweden|Investigational Site 3904, Kristianstad, Sweden|Investigational Site 3903, Stockholm, Sweden|Investigational Site 3905, Stockholm, Sweden|Investigational Site 3902, Sundsvall, Sweden|Investigational Site 4103, Aarau, Switzerland|Investigational Site 4110, Basel, Switzerland|Investigational Site 4104, Bellinzona, Switzerland|Investigational Site 4102, Chur, Switzerland|Investigational Site 4109, Lausanne, Switzerland|Investigational Site 4100, Luzern, Switzerland|Hualien City, Taiwan|Investigational Site 5104, Kaohsiung, Taiwan|Investigational Site 5105, Taichung, Taiwan|Investigational Site 5101, Taipei, Taiwan|Investigational Site 5103, Taipei, Taiwan|Investigational Site 5200, Bangkok, Thailand|Investigational Site 5202, Bangkok, Thailand|Investigational Site 5203, Nakhorn Nayok, Thailand|Investigational Site 5702, Ankara, Turkey|Investigational Site 5703, Ankara, Turkey|Investigational Site 5702, Istanbul, Turkey|Investigational Site 5706, Istanbul, Turkey|Chernigiv, Ukraine|Investigational Site 4008, Dnipropetrovsk, Ukraine|Investigational Site 4010, Donetsk, Ukraine|Investigational Site 4000, Ivano-Frankivsk, Ukraine|Investigational Site 4002, Kharkiv, Ukraine|Investigational Site 4001, Kiev, Ukraine|Investigational Site 4007, Ternopil, Ukraine|Investigational Site 4009, Uzhgorod, Ukraine|Investigational Site 4003, Vinnitsya, Ukraine|Investigational Site 4006, Zaporizhzhia, Ukraine|Investigational Site 7005, Coventry, United Kingdom|Investigational Site 7006, Hull, United Kingdom|Investigational Site 7000, London, United Kingdom|Investigational Site 7003, London, United Kingdom|Investigational Site 7004, London, United Kingdom|Investigational Site 7001, Newcastle, United Kingdom|Investigational Site 7007, Plymouth, United Kingdom",
